multiple endocrine neoplasia

Showing 1 - 12 of 12

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

A Retrospective Study for Multiple Endocrine Neoplasia

Recruiting
  • Multiple Endocrine Neoplasia
  • no intervention
  • Taipei, Taiwan
    National Taiwan University Hospital
Apr 2, 2023

Studies of Inherited Diseases of Metabolism

Completed
  • Multiple Endocrine Neoplasia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

    Recruiting
    • Rare Disorders
    • +309 more
      • Sioux Falls, South Dakota
      • +1 more
      Jun 20, 2022

      Hyperparathyroidism, Hypercalcemia, Parathyroid Tumor Trial run by the NIDDK (68Ga-Dotatate, 18F-DOPA)

      Completed
      • Hyperparathyroidism
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      May 12, 2022

      Psychosocial Aspects of Multiple Endocrine Neoplasia Syndromes

      Completed
      • Multiple Endocrine Neoplasia
      • Questionnaire
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Nov 17, 2020

      d to Developing Multiple Endocrine Neoplasia and Pancreatic

      Recruiting
      • Multiple Endocrine Neoplasia
      • +2 more
      • Genome Sequencing
      • Data Review
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Sep 11, 2019

      Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine

      Recruiting
      • Multiple Endocrine Neoplasia
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        May 21, 2019

        Study and Follow-up of Multiple Endocrine Neoplasia Type 1

        Recruiting
        • Multiple Endocrine Neoplasia
        • survey for long-term follow-up of the disease
        • Dijon, France
          CHU Dijon Bourgogne
        Nov 17, 2017

        Neuroendocrine Tumors, Carcinoid Tumors, Adrenal Gland Tumors Trial in Stanford (pertuzumab, erlotinib)

        Terminated
        • Neuroendocrine Tumors
        • +5 more
        • Stanford, California
          Stanford University School of Medicine
        Jan 12, 2017

        Zollinger-Ellison Syndrome, Multiple Endocrine Neoplasia Trial (Lansoprazole (Prevacid))

        Completed
        • Zollinger-Ellison Syndrome
        • Multiple Endocrine Neoplasia
        • Lansoprazole (Prevacid)
        • (no location specified)
        Oct 23, 2012

        Respiratory Tract Tumors, Thymic Tumors, Pancreatic Tumors Trial in Naples (Octreotide-LAR)

        Completed
        • Respiratory Tract Neoplasms
        • +4 more
        • Naples, Italy
          University Federico II of Naples
        Oct 6, 2009